Muramyl dipeptide protects decomplemented mice from surgically-induced infection
- 1 January 1986
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 8 (7) , 799-803
- https://doi.org/10.1016/0192-0561(86)90017-2
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Muramyl peptides. Variation of somnogenic activity with structure.The Journal of Experimental Medicine, 1984
- In vitro immune response to sheep erythrocytes in macrophage depleted cultures. Restoration with interleukine 1 or a monokine from resident macrophages and stimulation by N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP)Biochemical and Biophysical Research Communications, 1983
- Prostaglandin E2 modulation of human monocyte antibody-dependent cell-mediated cytotoxicity against human red blood cellsCellular Immunology, 1982
- In vivo regulation of humoral and cellular immune reponses of mice by a synthetic adjuvant, N-acetyl-muramyl-l-alanyl-d-isoglutamine, muramyl dipeptide for MDPCellular Immunology, 1979
- The macrophage, target cell of the synthetic adjuvant muramyl dipeptideEuropean Journal of Immunology, 1978
- Target cells for the activity of a synthetic adjuvant: Muramyl dipeptideCellular Immunology, 1977
- Cobra Venom Factor: Evidence for Its Being Altered Cobra C3 (the Third Component of Complement)Science, 1976
- Immunosuppression by cobra factor: Distribution, antigen-induced blast transformation and trapping of lymphocytes during in vivo complement depletionCellular Immunology, 1976
- Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble componentsCellular Immunology, 1976
- Total synthesis and adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1975